These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17942817)

  • 21. Albuterol improves response to levodopa and increases skeletal muscle mass in patients with fluctuating Parkinson disease.
    Uc EY; Lambert CP; Harik SI; Rodnitzky RL; Evans WJ
    Clin Neuropharmacol; 2003; 26(4):207-12. PubMed ID: 12897642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral albuterol dosing during the latter stages of a resistance exercise program.
    Caruso JF; Hamill JL; De Garmo N
    J Strength Cond Res; 2005 Feb; 19(1):102-7. PubMed ID: 15705021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Albuterol helps resistance exercise attenuate unloading-induced knee extensor losses.
    Caruso JF; Hamill JL; Yamauchi M; Mercado DR; Cook TD; Keller CP; Montgomery AG; Elias J
    Aviat Space Environ Med; 2004 Jun; 75(6):505-11. PubMed ID: 15198276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.
    D'Alonzo GE; Nathan RA; Henochowicz S; Morris RJ; Ratner P; Rennard SI
    JAMA; 1994 May; 271(18):1412-6. PubMed ID: 7909853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect and safety of treatment with ACE-inhibitor Enalapril and β-blocker metoprolol on the onset of left ventricular dysfunction in Duchenne muscular dystrophy - a randomized, double-blind, placebo-controlled trial.
    Dittrich S; Graf E; Trollmann R; Neudorf U; Schara U; Heilmann A; von der Hagen M; Stiller B; Kirschner J; Pozza RD; Müller-Felber W; Weiss K; von Au K; Khalil M; Motz R; Korenke C; Lange M; Wilichowski E; Pattathu J; Ebinger F; Wiechmann N; Schröder R;
    Orphanet J Rare Dis; 2019 May; 14(1):105. PubMed ID: 31077250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of creatine monohydrate in improving cellular energetics and muscle strength in ambulatory Duchenne muscular dystrophy patients: a randomized, placebo-controlled 31P MRS study.
    Banerjee B; Sharma U; Balasubramanian K; Kalaivani M; Kalra V; Jagannathan NR
    Magn Reson Imaging; 2010 Jun; 28(5):698-707. PubMed ID: 20395096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment with L-citrulline and metformin in Duchenne muscular dystrophy: study protocol for a single-centre, randomised, placebo-controlled trial.
    Hafner P; Bonati U; Rubino D; Gocheva V; Zumbrunn T; Gueven N; Fischer D
    Trials; 2016 Aug; 17(1):389. PubMed ID: 27488051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of sildenafil on skeletal and cardiac muscle in Becker muscular dystrophy.
    Witting N; Kruuse C; Nyhuus B; Prahm KP; Citirak G; Lundgaard SJ; von Huth S; Vejlstrup N; Lindberg U; Krag TO; Vissing J
    Ann Neurol; 2014 Oct; 76(4):550-7. PubMed ID: 25042931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temporal strength changes from resistance exercise and albuterol on unloaded muscle.
    Caruso JF; Hamill JL; Yamauchi M; Saito K; Cook TD; Mercado DR
    J Strength Cond Res; 2008 Jul; 22(4):1156-63. PubMed ID: 18545194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial.
    Lazarus SC; Boushey HA; Fahy JV; Chinchilli VM; Lemanske RF; Sorkness CA; Kraft M; Fish JE; Peters SP; Craig T; Drazen JM; Ford JG; Israel E; Martin RJ; Mauger EA; Nachman SA; Spahn JD; Szefler SJ;
    JAMA; 2001 May 23-30; 285(20):2583-93. PubMed ID: 11368732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhaled salmeterol and albuterol in asthmatic patients receiving high-dose inhaled corticosteroids.
    Lai CK; Chan CH; Ho SS; Hui AC; Lai KN
    Chest; 1995 Jul; 108(1):36-40. PubMed ID: 7606988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Albuterol extended-release products: a comparison of steady-state pharmacokinetics.
    Hussey EK; Donn KH; Powell JR
    Pharmacotherapy; 1991; 11(2):131-5. PubMed ID: 2052468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophy.
    Griggs RC; Miller JP; Greenberg CR; Fehlings DL; Pestronk A; Mendell JR; Moxley RT; King W; Kissel JT; Cwik V; Vanasse M; Florence JM; Pandya S; Dubow JS; Meyer JM
    Neurology; 2016 Nov; 87(20):2123-2131. PubMed ID: 27566742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing the effects of racemic and single-enantiomer albuterol on airway secretions in long-term intubated patients.
    O'Riordan TG; Mao W; Palmer LB; Chen JJ
    Chest; 2006 Jan; 129(1):124-32. PubMed ID: 16424422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual-energy X-ray absorptiometry measures of lean body mass as a biomarker for progression in boys with Duchenne muscular dystrophy.
    Sherlock SP; Palmer J; Wagner KR; Abdel-Hamid HZ; Tian C; Mah JK; Muntoni F; Guglieri M; Butterfield RJ; Charnas L; Marraffino S
    Sci Rep; 2022 Nov; 12(1):18762. PubMed ID: 36335191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative study of extended release albuterol sulfate and long-acting inhaled salmeterol xinafoate in the treatment of nocturnal asthma.
    Martin RJ; Kraft M; Beaucher WN; Kiechel F; Sublett JL; LaVallee N; Shilstone J
    Ann Allergy Asthma Immunol; 1999 Aug; 83(2):121-6. PubMed ID: 10480584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of subsensitivity to albuterol after treatment with salmeterol in patients with asthma.
    Nelson HS; Berkowitz RB; Tinkelman DA; Emmett AH; Rickard KA; Yancey SW
    Am J Respir Crit Care Med; 1999 May; 159(5 Pt 1):1556-61. PubMed ID: 10228126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A mouse anti-myostatin antibody increases muscle mass and improves muscle strength and contractility in the mdx mouse model of Duchenne muscular dystrophy and its humanized equivalent, domagrozumab (PF-06252616), increases muscle volume in cynomolgus monkeys.
    St Andre M; Johnson M; Bansal PN; Wellen J; Robertson A; Opsahl A; Burch PM; Bialek P; Morris C; Owens J
    Skelet Muscle; 2017 Nov; 7(1):25. PubMed ID: 29121992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A high dose of albuterol does not overcome bronchoprotective subsensitivity in asthmatic subjects receiving regular salmeterol or formoterol.
    Lipworth BJ; Aziz I
    J Allergy Clin Immunol; 1999 Jan; 103(1 Pt 1):88-92. PubMed ID: 9893190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma.
    Pearlman DS; Chervinsky P; LaForce C; Seltzer JM; Southern DL; Kemp JP; Dockhorn RJ; Grossman J; Liddle RF; Yancey SW
    N Engl J Med; 1992 Nov; 327(20):1420-5. PubMed ID: 1357554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.